{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:53:12Z","timestamp":1787500392004,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T00:00:00Z","timestamp":1626998400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.clindermatol.2021.07.011","type":"journal-article","created":{"date-parts":[[2021,7,25]],"date-time":"2021-07-25T01:20:43Z","timestamp":1627176043000},"page":"966-984","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["The histologic and molecular correlates of COVID-19 vaccine-induced changes in the skin"],"prefix":"10.1016","volume":"39","author":[{"given":"Cynthia","family":"Magro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Neil","family":"Crowson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Franks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panta Rouhani","family":"Schaffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Whelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Nuovo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2021.07.011_bib0001","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3390\/cells10020206","article-title":"COVID-19: characteristics and therapeutics","volume":"10","author":"Chilamakuri","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.clindermatol.2021.07.011_bib0002","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.anai.2021.01.017","article-title":"Insights from American College of Allergy, Asthma, and Immunology COVID-19 Vaccine Task Force: allergic reactions to mRNA SARS-CoV-2 vaccines","volume":"126","author":"Murphy","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.clindermatol.2021.07.011_bib0003","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41418-020-00720-9","article-title":"COVID-19 Commission of Accademia Nazionale dei Lincei, Rome. COVID-19 vaccines: where we stand and challenges ahead","volume":"28","author":"Forni","year":"2021","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.clindermatol.2021.07.011_bib0004","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41586-020-2814-7","article-title":"COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses","volume":"586","author":"Sahin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.clindermatol.2021.07.011_bib0005","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa2022483","article-title":"An mRNA vaccine against SARS-CoV-2\u2014preliminary report","volume":"383","author":"Jackson","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2021.07.011_bib0006","article-title":"Severe COVID-19: a multifaceted viral vasculopathy syndrome","volume":"50","author":"Magro","year":"2020","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.clindermatol.2021.07.011_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2020.04.007","article-title":"Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases","volume":"220","author":"Magro","year":"2020","journal-title":"Transl Res"},{"key":"10.1016\/j.clindermatol.2021.07.011_bib0008","article-title":"Endothelial cell damage is the central part of COVID-19 and a mouse model induced by injection of the S1 subunit of the spike protein","volume":"51","author":"Nuovo","year":"2020","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.clindermatol.2021.07.011_bib0009","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13045-020-00954-7","article-title":"SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19","volume":"13","author":"Zhang","year":"2020","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.clindermatol.2021.07.011_bib0010","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/DAD.0000000000000234","article-title":"Role of the skin biopsy in the diagnosis of atypical hemolytic uremic syndrome","volume":"37","author":"Magro","year":"2015","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.clindermatol.2021.07.011_bib0011","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.humpath.2020.10.002","article-title":"Docked severe acute respiratory syndrome coronavirus 2 proteins within the cutaneous and subcutaneous microvasculature and their role in the pathogenesis of severe coronavirus disease 2019","volume":"106","author":"Mulvey","year":"2020","journal-title":"Hum Pathol"},{"key":"10.1016\/j.clindermatol.2021.07.011_bib0012","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1046\/j.1365-4362.1997.00010.x","article-title":"A distinctive vesiculopustular eruption associated with hepatobiliary disease","volume":"36","author":"Magro","year":"1997","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.07.011_bib0013","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1600-0560.1998.tb01722.x","article-title":"Sterile neutrophilic folliculitis with perifollicular vasculopathy: a distinctive cutaneous reaction pattern reflecting systemic disease","volume":"25","author":"Magro","year":"1998","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.clindermatol.2021.07.011_bib0014","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1034\/j.1600-0560.2003.00024.x","article-title":"Pyoderma gangrenosum: a review","volume":"37","author":"Crowson","year":"2003","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.clindermatol.2021.07.011_bib0015","unstructured":"Janssen Vaccines & Prevention B.V. Clinical Trials. A randomized, double-blind, placebo-controlled phase 3 study to assess the efficacy and safety of Ad26. COV2. S for the prevention of SARS-CoV-2-mediated COVID-19 in adults aged 18 years and older. https\/\/clinicaltrials.gov\/ct2\/show\/NCT04505722. Accessed August 3, 2021."},{"key":"10.1016\/j.clindermatol.2021.07.011_bib0016","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/258430","article-title":"Possible triggering effect of influenza vaccination on psoriasis","volume":"2015","author":"Gunes","year":"2015","journal-title":"J Immunol Res"},{"key":"10.1016\/j.clindermatol.2021.07.011_bib0017","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jaad.2021.03.092","article-title":"Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases","volume":"85","author":"McMahon","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2021.07.011_bib0018","unstructured":"Food and Drug Administration. FDA briefing document: Janssen Ad26. COV2. S vaccine for the prevention of COVID-19. Vaccines and Related Biological Products Advisory Committee Meeting. https\/\/fda.gov\/media\/\/146217\/download. Accessed August 3, 2021."},{"key":"10.1016\/j.clindermatol.2021.07.011_bib0019","doi-asserted-by":"crossref","unstructured":"Farinazzo E, Ponis G, Zelin E, et\u00a0al. Cutaneous adverse reactions after m-RNA COVID-19 vaccine: early reports from Northeast Italy [e-pub ahead of print]. J Eur Acad Dermatol Venereol. doi:10.1111\/jdv.17343, accessed May 22, 2021.","DOI":"10.1111\/jdv.17343"},{"key":"10.1016\/j.clindermatol.2021.07.011_bib0020","doi-asserted-by":"crossref","unstructured":"Cross R. The tiny tweak behind COVID-19 vaccines. Chemical Engineering News. https\/\/cen.acs.org\/pharmaceuticals\/vaccines\/tiny-tweak-behind-COVID-19\/98\/i38. Accessed August 3, 2021.","DOI":"10.1021\/cen-09838-feature1"},{"key":"10.1016\/j.clindermatol.2021.07.011_bib0021","first-page":"249","article-title":"Diagnosis and management of contact dermatitis","volume":"82","author":"Usatine","year":"2010","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.clindermatol.2021.07.011_bib0022","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1600-0536.1984.tb00343.x","article-title":"The baboon syndrome: systemically-induced allergic contact dermatitis","volume":"10","author":"Andersen","year":"1984","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.clindermatol.2021.07.011_bib0023","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1182\/blood.2021011548","article-title":"COVID-19 vaccines induce severe hemolysis in paroxysmal nocturnal hemoglobinuria","volume":"137","author":"Gerber","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.clindermatol.2021.07.011_bib0024","unstructured":"Centers for Disease Control and Prevention. Myocarditis and pericarditis following mRNA COVID-19 vaccination. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/safety\/myocarditis.html. Accessed August 3, 2021."},{"key":"10.1016\/j.clindermatol.2021.07.011_bib0025","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jgg.2021.02.006","article-title":"Covid-19 mRNA vaccines","volume":"48","author":"Huang","year":"2021","journal-title":"J Genet Genomics"},{"key":"10.1016\/j.clindermatol.2021.07.011_bib0026","unstructured":"Magro CM, Scheck L, Soleymani AD. Unmasking of a TH1-mediated vitiligo-like tendency in the setting of dupilumab therapy for adult atopic dermatitis. The Dermatologist. https:\/\/www.hmpgloballearningnetwork.com\/site\/thederm\/article\/unmasking-th1-mediated-vitiligo-tendency-setting-dupilumab-therapy-adult-atopic-dermatitis. Accessed August 3, 2021."},{"key":"10.1016\/j.clindermatol.2021.07.011_bib0027","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/014107689809100305","article-title":"Exacerbation of atopic dermatitis after bacillus Calmette-Gu\u00e9rin vaccination","volume":"91","author":"Dalton","year":"1998","journal-title":"J R Soc Med"},{"key":"10.1016\/j.clindermatol.2021.07.011_bib0028","doi-asserted-by":"crossref","unstructured":"Krajewski PK, Matusiak \u0141, Szepietowski JC. Psoriasis flare-up associated with second dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine [e-pub ahead of print]. J Eur Acad Dermatol Venereol. doi:10.1111\/jdv.17449, accessed 16 Jun, 2021.","DOI":"10.1111\/jdv.17449"},{"key":"10.1016\/j.clindermatol.2021.07.011_bib0029","doi-asserted-by":"crossref","unstructured":"Ogata AF, Cheng C, Desjardins M, et\u00a0al. Circulating SARS-CoV-2 vaccine antigen detected in the plasma of mRNA-1273 vaccine recipients [e-pub ahead of print]. Clin Inf Dis. doi:10.1093\/cid\/ciab465, accessed 20 May, 2021.","DOI":"10.1093\/cid\/ciab465"},{"key":"10.1016\/j.clindermatol.2021.07.011_bib0030","doi-asserted-by":"crossref","first-page":"n1244","DOI":"10.1136\/bmj.n1244","article-title":"Covid-19 vaccines: in the rush for regulatory approval, do we need more data?","volume":"373","author":"Doshi","year":"2021","journal-title":"BMJ"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X21001516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X21001516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:18:04Z","timestamp":1760033884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X21001516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0738081X21001516"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2021.07.011","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The histologic and molecular correlates of COVID-19 vaccine-induced changes in the skin","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2021.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}